Product
Dose A VTX958
1 clinical trial
1 indication
Indication
Psoriatic ArthritisClinical trial
A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of VTX958 in Patients With Active Psoriatic ArthritisStatus: Terminated, Estimated PCD: 2024-01-02